Skip to main content
logo
PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
2.400
+0.155 (6.90%)
Sep 17, 2026, 4:10 PM AEST

PYC Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
25.9925.9923.4922.0615.8116.04
Revenue Growth
26.44%10.64%6.50%39.56%-1.47%421.83%
Gross Profit
25.9925.9923.4922.0615.8116.04
Operating Income
-57.41-57.41-53.63-38.86-23.43-14.29
Net Income
-43.34-43.34-50.3-37.73-22.79-13.86
Earnings Per Share
-0.06-0.06-0.10-0.10-0.07-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
447.56447.56153.0566.8715.5729.11
Total Debt
0.620.621.021.110.320.94
Net Cash (Debt)
446.94446.94152.0365.7615.2628.17
Net Cash Growth
272.87%193.99%131.18%331.05%-45.84%-44.52%
Net Cash Per Share
0.610.610.300.170.050.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-44.52-44.52-51.56-38.59-24.42-21.78
Capital Expenditures
-0.53-0.53-0.98-0.31-0.49-0.39
Free Cash Flow
-45.05-45.05-52.54-38.9-24.91-22.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-220.86%-220.86%-228.26%-176.15%-148.24%-89.05%
Pretax Margin
-168.37%-168.37%-217.13%-172.76%-147.77%-89.10%
Profit Margin
-166.73%-166.73%-214.11%-171.02%-144.18%-86.41%
FCF Margin
-173.31%-173.31%-223.61%-176.32%-157.61%-138.19%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-20.0020.0020.0020.0020.00
PS Ratio
90.8163.7532.1525.3812.1012.89